Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

causing the mitral valve annulus to also dilate and prevent the mitral valve leaflets from properly coapting. There are many causes of left atrial and left ventricular dilation, and the treatment ...

Cosgrove brings a unique perspective to the field of mitral valve repair with the development ... Integral template provides a measured plication of the annulus for predictable, reproducible ...

known as primary MR (or “organic” MR), or due to dilation of the mitral valve annulus associated with impaired left ventricular function, known as secondary MR (or “functional” MR).

the line of coaptation in the mitral valve is destroyed. If the ventricle dilates, if you think about it, the annulus pulls apart and all of a sudden coaptation no longer can occur. Or ...

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

The mitral valve is the most commonly repaired heart ... the faulty valve is removed and a new valve is sewn to the annulus of your original valve. The new valve can be a: Yes.

Marks, Joseph H. — Roentgenologist, Truesdale Hospital, Fall River, Mass. For record and address of author see "This Week's Issue," page 436.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical ... the addition of moderate and severe mitral annular calcification.

The role for CABG in patients with heart failure depends upon myocardial viability and adequacy of target vessels for revascularization. The presence of heart failure with congestive heart failure ...